| Anduril 2: upgraded large-scale data integration framework A Cervera, V Rantanen, K Ovaska, M Laakso, J Nunez-Fontarnau, ... Bioinformatics 35 (19), 3815-3817, 2019 | 36 | 2019 |
| Prospective longitudinal ctDNA workflow reveals clinically actionable alterations in ovarian cancer J Oikkonen, K Zhang, L Salminen, I Schulman, K Lavikka, N Andersson, ... JCO Precision Oncology 3, 1-12, 2019 | 31 | 2019 |
| Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma A Lahtinen, K Lavikka, A Virtanen, Y Li, S Jamalzadeh, A Skorda, ... Cancer Cell 41 (6), 1103-1117. e12, 2023 | 16 | 2023 |
| A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids W Senkowski, L Gall-Mas, MM Falco, Y Li, K Lavikka, MC Kriegbaum, ... Developmental Cell 58 (12), 1106-1121. e7, 2023 | 15 | 2023 |
| Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer F Perez-Villatoro, J Oikkonen, J Casado, A Chernenko, DC Gulhan, ... npj precision oncology 6 (1), 96, 2022 | 11 | 2022 |
| Evolutionary states and trajectories characterized by distinct pathways stratify ovarian high-grade serous carcinoma patients A Lahtinen, K Lavikka, Y Li, A Virtanen, S Jamalzadeh, K Huhtinen, ... bioRxiv, 2022.08. 30.505808, 2022 | 3 | 2022 |
| Grammar-Based Interactive Genome Visualization K Lavikka Master’s thesis, Helsingin yliopisto, 2020 | 3 | 2020 |
| GenomeSpy: grammar-based interactive genome visualization K Lavikka, J Oikkonen, R Lehtonen, J Hynninen, S Hietanen, ... F1000Res. 9, 2020 | 3 | 2020 |
| Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma S Jamalzadeh, J Dai, K Lavikka, Y Li, J Jiang, K Huhtinen, A Virtanen, ... BMC cancer 24 (1), 173, 2024 | 2 | 2024 |
| HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma H Koskela, Y Li, T Joutsiniemi, T Muranen, VM Isoviita, K Huhtinen, ... Gynecologic Oncology 180, 91-98, 2024 | 2 | 2024 |
| A platform for efficient establishment, expansion and drug response profiling of high-grade serous ovarian cancer organoids W Senkowski, L Gall-Mas, MM Falco, Y Li, K Lavikka, MC Kriegbaum, ... bioRxiv, 2022.04. 21.489027, 2022 | 2 | 2022 |
| Optimized detection of allelic imbalances specific for homologous recombination deficiency improves the prediction of clinical outcomes in cancer F Perez-Villatoro, J Oikkonen, J Casado, A Chernenko, DC Gulhan, ... bioRxiv, 2021.08. 19.456809, 2021 | 2 | 2021 |
| 776P Multi-omics analysis of chemo-refractory high-grade serous carcinoma patients: Insights from the DECIDER study D Afenteva, TA Muranen, A Rajavuori, S Jamalzadeh, K Zhang, V Ariotta, ... Annals of Oncology 34, S525, 2023 | 1 | 2023 |
| Deciphering Cancer Genomes with GenomeSpy: A Grammar-Based Visualization Toolkit K Lavikka, J Oikkonen, Y Li, T Muranen, G Micoli, G Marchi, A Lahtinen, ... bioRxiv, 2023.10. 06.561159, 2023 | 1 | 2023 |
| H&E image analysis pipeline for quantifying morphological features V Ariotta, O Lehtonen, S Salloum, G Micoli, K Lavikka, V Rantanen, ... Journal of pathology informatics 14, 100339, 2023 | 1 | 2023 |
| Application of high-grade serous ovarian cancer organoids in functional precision medicine W Senkowski, L Gall-Mas, MM Falco, Y Li, K Lavikka, A Crispino, ... Cancer Research 84 (6_Supplement), 235-235, 2024 | | 2024 |
| Integrative DNA methylation cancer profiling reveals patterns associated with tumor progression and treatment response A Lahtinen, G Marchi, D Afenteva, K Lavikka, S Holmström, E Pöllänen, ... Cancer Research 84 (6_Supplement), 7014-7014, 2024 | | 2024 |
| Tumor evolution during therapy in ovarian cancer SK Hautaniemi, J Oikkonen, A Lahtinen, MTN Nguyen, G Marchi, ... Cancer Research 84 (6_Supplement), 1617-1617, 2024 | | 2024 |
| Abstract A027: Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma S Hautaniemi, S Jamalzadeh, J Dai, K Lavikka, Y Li, K Huhtinen, ... Cancer Research 84 (5_Supplement_2), A027-A027, 2024 | | 2024 |
| Abstract A003: Characterizing DNA methylation patterns driving chemotherapy resistance in ovarian high-grade serous carcinoma A Lahtinen, G Marchi, K Lavikka, G Micoli, S Holmström, E Pöllänen, ... Cancer Research 84 (5_Supplement_2), A003-A003, 2024 | | 2024 |
